Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Management of Lung Cancer in the Era of COVID-19
-
+
MA12.01 - A Novel Program Offering Remote, Asynchronous Subspecialist Input in Thoracic Oncology: Early Experience During a Pandemic
20:00 - 20:05 | Presenter: Howard West
- Abstract
Loading... -
+
MA12.02 - Factors Associated with Severe COVID-19 Infections in Lung Cancer Patients
20:05 - 20:10 | Presenter: Apar Kishor Ganti
- Abstract
Loading... -
+
MA12.03 - A Thoracic Cancers International COVID 19 Collaboration Survey on Patients’ Perceptions of COVID-19 (Teravolt-Paper)
20:10 - 20:15 | Presenter: Selina K Wong
- Abstract
Loading... -
+
MA12.04 - Discussant
20:15 - 20:30 | Presenter: Brendon Stiles
- Abstract
No abstract available for this presentation
-
+
MA12.05 - The Impact of the COVID-19 Pandemic on Post-Operative Outcomes of Thoracic Cancer Surgery in Canada
20:30 - 20:35 | Presenter: Caroline Huynh
- Abstract
Loading... -
+
MA12.06 - Single Fraction Lung Stereotactic Body Radiotherapy Implementation in a Multi-Center Provincial Cancer Program During the COVID-19 Pandemic
20:35 - 20:40 | Presenter: Benjamin Mou
- Abstract
Loading... -
+
MA12.07 - Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center
20:40 - 20:45 | Presenter: Maristella Bungaro
- Abstract
Loading... -
+
MA12.08 - Discussant
20:45 - 21:00 | Presenter: Sara Pilotto
- Abstract
No abstract available for this presentation
-
+
OA16 - Clinical Impact of Liquid Biopsy for Patients with NSCLC
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
- Moderators:Sarah B Goldberg
-
+
OA16.01 - Plasma NGS At Time of Diagnostic Tissue Biopsy – Impact on Time to Treatment: Results From a Pilot Prospective Study
20:00 - 20:10 | Presenter: Jeffrey C. Thompson
- Abstract
Loading... -
+
OA16.02 - The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer
20:10 - 20:20 | Presenter: Doreen Ezeife
- Abstract
Loading... -
+
OA16.03 - Matched Targeted Therapy by cfDNA of CSF Beyond Leptomeningeal Metastases Progression Upon Osimertinib in EGFR-Mutated NSCLC Patients
20:20 - 20:30 | Presenter: Mei-Mei Zheng
- Abstract
Loading... -
+
OA16.04 - A Combined Model of Clinical, Imaging and DNA Methylation Biomarkers to Improve the Classification of Pulmonary Nodules
20:30 - 20:40 | Presenter: Jianxing HE
- Abstract
Loading... -
+
OA16.05 - Discussant
20:40 - 20:50 | Presenter: Lecia V. Sequist
- Abstract
No abstract available for this presentation
-
+
OA16.06 - Live Discussion with Speakers
20:50 - 21:00
- Abstract
No abstract available for this presentation
-
+
OA17 - Multidisciplinary Care of Thoracic Oncology Patients During COVID-19 Pandemic
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Nursing and Allied Health Professionals
- Moderators:Sara McLaughlin-Barrett
-
+
OA17.01 - Core Supportive Care for People Living With Lung Cancer During COVID-19: Analyses of Specialist Lung Cancer Nursing Practice
20:00 - 20:10 | Presenter: Vanessa Brunelli
- Abstract
Loading... -
+
OA17.02 - COVID-19 Pandemic and Mental Health Status of Lung Cancer Patients in Indonesia
20:10 - 20:20 | Presenter: Hanna Lianti Afladhia
- Abstract
Loading... -
+
OA17.03 - Clinical and Social Impact of COVID-19 Pandemic in Patients with Thoracic Malignancies
20:20 - 20:30 | Presenter: Oscar Arrieta
- Abstract
Loading... -
+
OA17.04 - The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers
20:30 - 20:40 | Presenter: Anne-Marie Baird
- Abstract
Loading... -
+
OA17.05 - Discussant
20:40 - 20:50 | Presenter: Michelle Turner
- Abstract
No abstract available for this presentation
-
+
OA17.06 - Live Discussion with Speakers
20:50 - 21:00
- Abstract
No abstract available for this presentation
-
+
IS11 - Satellite CME Symposium by Medscape: Answers to Key Questions About Molecular Alterations Within NSCLC: How Do You Stack Up?
- 21:15 - 22:15
- 9/12/2021
- Location: Program Auditorium
- CME Accredited by Other Provider
- Type: Satellite CME Symposia
- Track: N.A.
-
+
IS11.01 - Introduction
21:15 - 21:15 | Presenter: Zofia Piotrowska
- Abstract
No abstract available for this presentation
-
+
IS11.02 - Key Questions for Practice: Optimizing the Diagnosis and Management of Patients with NSCLC and Molecular Alterations
21:15 - 21:15 | Presenter: Zofia Piotrowska, Joshua Sabari, Maureen Zakowski
- Abstract
No abstract available for this presentation
-
+
IS11.03 - Conclusions and Q&A
21:15 - 21:15 | Presenter: Zofia Piotrowska
- Abstract
No abstract available for this presentation
-
+
IS11.04 - Backstage Pass Breakout Session (Optional)
21:15 - 21:15
- Abstract
No abstract available for this presentation
-
+
IS12 - Satellite CME Symposium by Research To Practice: Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Early-Stage Non-Small Cell Lung Cancer
- 21:15 - 22:15
- 9/12/2021
- Location: Program Auditorium
- CME Accredited by Other Provider
- Type: Satellite CME Symposia
- Track: N.A.
-
+
IS12.01 - Established Management Paradigm for Early-Stage Non-Small Cell Lung Cancer (NSCLC)
21:15 - 21:35
- Abstract
No abstract available for this presentation
-
+
IS12.02 - Emerging Role of Immune Checkpoint Inhibitors as Neoadjuvant or Adjuvant Therapy for Localized NSCLC
21:35 - 21:55
- Abstract
No abstract available for this presentation
-
+
IS12.03 - Optimal Approaches to the Monitoring and Management of Toxicities in Patients Receiving Neoadjuvant or Adjuvant Anti-PD-1/PD-L1 Antibody Therapy
21:55 - 22:15
- Abstract
No abstract available for this presentation
first
prev